Ibrance®

Active substance

 palbociclib

Holder

 Pfizer

Status

Closed

Indication

 patients suffering from advanced/metastatic breast cancer hormone receptor (HR)‑positive, human epidermal growth factor receptor 2 (HER2)‑negative with endocrine therapy

Public documents

Approbation

Information for the patient

Informed consent

Last update

27/07/2018
Last updated on